Emergency management in patients with haemophilia A and inhibitors on prophylaxis with emicizumab: AICE practical guidance in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET

Emicizumab has been approved in several countries for regular prophylaxis in patients with congenital haemophilia A and FVIII inhibitors because it substantially reduces their bleeding risk and improves quality of life. However, although significantly less frequent, some breakthrough bleeds may stil...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Blood Transfus
Main Authors: Castaman, Giancarlo, Santoro, Cristina, Coppola, Antonio, Mancuso, Maria E., Santoro, Rita C., Bernardini, Sergio, Pugliese, Francesco R., Lubrano, Riccardo, Golato, Maria, Tripodi, Armando, Rocino, Angiola, Santagostino, Elena, Biasoli, Chiara, Borchiellini, Alessandra, Catalano, Alberto, Contino, Laura, Coluccia, Antonella, Cultrera, Dorina, De Cristofaro, Raimondo, Di Minno, Giovanni, Fabbri, Andrea, Franchini, Massimo, Gamba, Gabriella, Giuffrida, Anna Chiara, Gresele, Paolo, Giampaolo, Adele, Hassan, Hamisa J., Luciani, Matteo, Marchesini, Emanuela, Marino, Renato, Mazzucconi, Maria Gabriella, Molinari, Angelo C., Morfini, Massimo, Notarangelo, Lucia D., Peccarisi, Lucia, Peyvandi, Flora, Pollio, Berardino, Rivolta, Gianna Franca, Ruggieri, Maria Pia, Sargentini, Vittorio, Schiavoni, Mario, Sciacovelli, Laura, Serino, Maria Luisa, Siragusa, Sergio, Tagliaferri, Annarita, Testa, Sophie, Tosetto, Alberto, Zampogna, Stefania, Zanon, Ezio
פורמט: Artigo
שפה:Inglês
יצא לאור: Edizioni SIMTI - SIMTI Servizi Srl 2020
נושאים:
Haemostasis
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7141940/
https://ncbi.nlm.nih.gov/pubmed/31657709
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2450/2019.0186-19
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים